ViroGates A/S (CPH:VIRO)

ViroGates Statistics

Total Valuation

ViroGates has a market cap or net worth of DKK 132.65 million. The enterprise value is 128.31 million.

Market Cap	132.65M
Enterprise Value	128.31M

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ViroGates has 7.73 million shares outstanding. The number of shares has increased by 20.01% in one year.

Current Share Class	7.73M
Shares Outstanding	7.73M
Shares Change (YoY)	+20.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.61%
Owned by Institutions (%)	n/a
Float	2.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.36
PB Ratio	46.79
P/TBV Ratio	46.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.36
EV / Sales	15.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 1.69.

Current Ratio	1.81
Quick Ratio	1.53
Debt / Equity	1.69
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.93

Financial Efficiency

Return on equity (ROE) is -249.66% and return on invested capital (ROIC) is -78.21%.

Return on Equity (ROE)	-249.66%
Return on Assets (ROA)	-55.33%
Return on Invested Capital (ROIC)	-78.21%
Return on Capital Employed (ROCE)	-193.43%
Revenue Per Employee	1.16M
Profits Per Employee	-1.77M
Employee Count	10
Asset Turnover	0.57
Inventory Turnover	0.98

Taxes

Income Tax	-902,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.04% in the last 52 weeks. The beta is 0.96, so ViroGates's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+27.04%
50-Day Moving Average	12.53
200-Day Moving Average	9.98
Relative Strength Index (RSI)	65.23
Average Volume (20 Days)	3,823

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ViroGates had revenue of DKK 8.11 million and -12.39 million in losses. Loss per share was -1.60.

Revenue	8.11M
Gross Profit	5.45M
Operating Income	-12.52M
Pretax Income	-13.29M
Net Income	-12.39M
EBITDA	n/a
EBIT	-12.52M
Loss Per Share	-1.60

Balance Sheet

The company has 9.12 million in cash and 4.78 million in debt, giving a net cash position of 4.34 million or 0.56 per share.

Cash & Cash Equivalents	9.12M
Total Debt	4.78M
Net Cash	4.34M
Net Cash Per Share	0.56
Equity (Book Value)	2.84M
Book Value Per Share	0.37
Working Capital	6.29M

Cash Flow

Operating Cash Flow	-5.92M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 67.25%, with operating and profit margins of -154.33% and -152.77%.

Gross Margin	67.25%
Operating Margin	-154.33%
Pretax Margin	-163.89%
Profit Margin	-152.77%
EBITDA Margin	n/a
EBIT Margin	-154.33%
FCF Margin	n/a

Dividends & Yields

ViroGates does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.01%
Shareholder Yield	-20.01%
Earnings Yield	-9.34%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ViroGates has an Altman Z-Score of 1.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.72
Piotroski F-Score	3